Core Scientific has secured a strategic loan facility from Morgan Stanley, offering up to $1 billion in financing. The agreement includes an initial $500 million 364-day loan facility, with the potential for expansion through an accordion option that could increase total commitments by another $500 million. This financial move reflects a strategic effort to bolster Core Scientific’s resources for its ongoing and future operations.
Core Scientific has secured up to $1 billion in financing from Morgan Stanley through a loan facility designed to support its strategic initiatives. The initial phase of the facility includes a $500 million 364-day loan with an interest rate based on the Secured Overnight Financing Rate (SOFR) plus 2.50%. Additionally, an accordion option allows for the expansion of total commitments by another $500 million.
The funds from this loan facility are intended for general corporate purposes directly associated with the development of data centers. This includes purchasing equipment, covering early-stage project costs, acquiring land, and finalizing energy supply agreements.
Importantly, this capital injection underpins Core Scientific’s pivot towards AI infrastructure, enabling the company to advance rapidly in this area. The strategic financing aligns with the company’s broader goals, enhancing its ability to meet growing demands in the technology sector.
Core Scientific recently disclosed its Q4 earnings, revealing significant financial activity. The company announced the sale of $175 million worth of bitcoin, which played a notable part in its financial strategy. The disclosure coincided with its announcement of securing a substantial loan facility from Morgan Stanley. In the market, shares of Core Scientific saw a slight decline, with a drop of approximately 1% in pre-market trading. This market response reflects investor reactions to the company’s latest financial decisions and strategic pivots.
Core Scientific’s recently arranged financing provides capital to advance the company’s data center development and related infrastructure projects. The funding supports the company’s operational activities and underpins its shift toward AI infrastructure by enabling continued project development and the scaling of facilities. Taken together, the financing is intended to strengthen Core Scientific’s capacity to develop and deploy infrastructure assets aligned with its evolving business focus.
